TriSalus Life Sciences Net Income 2021-2024 | TLSI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

TriSalus Life Sciences net income from 2021 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

TriSalus Life Sciences Net Income 2021-2024 | TLSI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

TriSalus Life Sciences net income from 2021 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$203.2B
Stryker (SYK)	$148.2B
Boston Scientific (BSX)	$133.1B
EssilorLuxottica (ESLOY)	$113.5B
Medtronic (MDT)	$109B
Haleon (HLN)	$42.9B
Lonza Group Ag (LZAGY)	$42.1B
GE HealthCare Technologies (GEHC)	$37.7B
ResMed (RMD)	$35B
Terumo (TRUMY)	$29.2B
Koninklijke Philips (PHG)	$24.4B
Zimmer Biomet Holdings (ZBH)	$22.1B
Insulet (PODD)	$18.4B
Baxter (BAX)	$16.6B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$9.5B
Bio-Rad Laboratories (BIO)	$9B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$5.5B
TG Therapeutics (TGTX)	$4.7B
Haemonetics (HAE)	$4.3B
ICU Medical (ICUI)	$4.2B
Prestige Consumer Healthcare (PBH)	$4.1B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.5B
Neogen (NEOG)	$3.3B
Agios Pharmaceuticals (AGIO)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.6B